Raffles Medical Group Ltd (BSL.SI)
SGD 0.83
(-1.19%)
SGD 0.83
(-1.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 189.31 Million | 196.22 Million | 160.11 Million | 133.14 Million | 111.14 Million | 91.52 Million |
| Net Income | 90.15 Million | 143.7 Million | 83.71 Million | 64.67 Million | 60.52 Million | 70.8 Million |
| Depreciation & Amortization | 38.24 Million | 40.21 Million | 39.32 Million | 35.49 Million | 29.26 Million | 18.27 Million |
| Deferred income taxes | - | 37.98 Million | 14.82 Million | 19.69 Million | 929 Thousand | -4.21 Million |
| Stock-based compensation | 3.4 Million | 3.16 Million | 2.46 Million | 1.61 Million | 1.39 Million | 1.46 Million |
| Change in working capital | 95.98 Million | -32.86 Million | 14.17 Million | 7.7 Million | 18.79 Million | 5.1 Million |
| Other non-cash items | -38.47 Million | 4.02 Million | 5.6 Million | 3.96 Million | 244 Thousand | 101 Thousand |
| Investing Cash Flow | -12.4 Million | -22.83 Million | -52.19 Million | -62.18 Million | -96.87 Million | -102.65 Million |
| Investments in PPE | -20.52 Million | -25.29 Million | -52.86 Million | -63.47 Million | -98.37 Million | -31.4 Million |
| Acquisitions | 519 Thousand | 161 Thousand | 45 Thousand | 6000.00 | 3000.00 | -2.29 Million |
| Investment purchases | - | - | -65 Thousand | -35 Thousand | -105 Thousand | -72.44 Million |
| Sales/Maturities of investments | - | - | 2.94 Million | 42 Thousand | 2.39 Million | - |
| Other Investing Activities | 8.11 Million | 2.3 Million | -2.25 Million | 1.27 Million | -782 Thousand | -71.24 Million |
| Financing Cash Flow | -85.52 Million | -183.7 Million | -46.87 Million | -20.87 Million | 31.54 Million | 20.07 Million |
| Debt repayment | -11.46 Million | -180.02 Million | -40.05 Million | -55.39 Million | -118.65 Million | -439.95 Million |
| Dividends payments | -70.68 Million | -52.01 Million | -37.34 Million | -19.18 Million | -17.95 Million | -15.63 Million |
| Common Stock Repurchased | -5.69 Million | -24.34 Million | -3.23 Million | - | -400 Thousand | 477.29 Million |
| Common Stock Issuance | 7.44 Million | 6.03 Million | 5.59 Million | 778 Thousand | 982 Thousand | 771 Thousand |
| Other Financing Activities | 2.32 Million | 66.64 Million | 28.16 Million | 52.92 Million | 167.57 Million | -2.41 Million |
| Accounts receivables | 95.35 Million | -31.7 Million | -48.32 Million | -30.29 Million | -1.38 Million | 4.83 Million |
| Accounts payables | -37.33 Million | -7.01 Million | 61.11 Million | 37.83 Million | 14.98 Million | -3.08 Million |
| Inventory | 633 Thousand | 276 Thousand | 1.21 Million | -4.34 Million | -925 Thousand | 635 Thousand |
| Other working capital | 19.37 Million | 5.58 Million | 169 Thousand | 4.5 Million | 6.11 Million | 4.47 Million |
| Cash at beginning of period | 252.05 Million | 263.9 Million | 202.05 Million | 150.74 Million | 105.98 Million | 98.27 Million |
| Cash at end of period | 342.54 Million | 252.05 Million | 263.9 Million | 202.05 Million | 150.74 Million | 105.98 Million |
| Capital Expenditure | -20.52 Million | -25.29 Million | -52.86 Million | -63.47 Million | -98.37 Million | -31.4 Million |
| Effect of forex changes on cash | -891 Thousand | -1.54 Million | 811 Thousand | 1.22 Million | -1.05 Million | -1.23 Million |
| Net cash flow / Change in cash | 90.48 Million | -11.85 Million | 61.85 Million | 51.3 Million | 44.76 Million | 7.71 Million |
| Free Cash Flow | 168.78 Million | 170.92 Million | 107.24 Million | 69.67 Million | 12.76 Million | 60.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 15.32 Million | 15.32 Million | 15.14 Million | 90.15 Million | 15.14 Million | 29.92 Million |
| Depreciation & Amortization | 9.94 Million | 9.36 Million | 9.03 Million | 37.03 Million | 9.03 Million | 9.51 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 912 Thousand | 912 Thousand | 777 Thousand | 3.4 Million | 777 Thousand | 926 Thousand |
| Change in working capital | -11.39 Million | -11.39 Million | 18.76 Million | 88.91 Million | 18.76 Million | 345.5 Thousand |
| Other non-cash items | 2.5 Million | 3.08 Million | -12.41 Million | -17.23 Million | -12.41 Million | 22.63 Million |
| Investing Cash Flow | -3.3 Million | -3.3 Million | -3.45 Million | -21.41 Million | -3.45 Million | -2.75 Million |
| Investments in PPE | -5.83 Million | -5.83 Million | -5.52 Million | -21.93 Million | -5.52 Million | -4.73 Million |
| Acquisitions | -481 Thousand | - | 519 Thousand | 519 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2.53 Million | 2.53 Million | 2.07 Million | 8.11 Million | 2.07 Million | 1.98 Million |
| Financing Cash Flow | -27.5 Million | -27.5 Million | -6.4 Million | -81.54 Million | -6.4 Million | -36.36 Million |
| Debt repayment | -740 Thousand | - | -148 Thousand | -79 Thousand | - | -69 Thousand |
| Dividends payments | -22.28 Million | -22.28 Million | - | -70.68 Million | - | -35.34 Million |
| Common Stock Repurchased | - | - | -2.84 Million | -5.69 Million | -2.84 Million | - |
| Common Stock Issuance | 251 Thousand | - | 1.19 Million | 7.44 Million | - | 6.24 Million |
| Other Financing Activities | -5.21 Million | -5.21 Million | -3.55 Million | -18 Thousand | -3.55 Million | -1.01 Million |
| Accounts receivables | -11.87 Million | -11.87 Million | 27.87 Million | 106.25 Million | 27.87 Million | 253.5 Thousand |
| Accounts payables | -6.21 Million | - | -32.71 Million | -37.33 Million | - | -4.62 Million |
| Inventory | 479.5 Thousand | 479.5 Thousand | 224.5 Thousand | 633 Thousand | 224.5 Thousand | 92 Thousand |
| Other working capital | 13.73 Million | - | -9.33 Million | 19.37 Million | -9.33 Million | 18.67 Million |
| Cash at beginning of period | 343.59 Million | - | 300.69 Million | 253.12 Million | 299.61 Million | 253.12 Million |
| Cash at end of period | 316.32 Million | -13.14 Million | 343.59 Million | 343.59 Million | 21.46 Million | 299.61 Million |
| Capital Expenditure | -5.83 Million | -5.83 Million | -5.52 Million | -21.93 Million | -5.52 Million | -4.73 Million |
| Effect of forex changes on cash | 383.5 Thousand | 383.5 Thousand | 11.5 Thousand | -891 Thousand | 11.5 Thousand | -457 Thousand |
| Net cash flow / Change in cash | -27.27 Million | -13.14 Million | 42.9 Million | 90.47 Million | -278.14 Million | 46.48 Million |
| Free Cash Flow | 11.44 Million | 11.44 Million | 25.78 Million | 172.41 Million | 25.78 Million | 58.6 Million |
SYNC-B
ESOA
3989
CBGPF
CIG-C
CMTL